66 related articles for article (PubMed ID: 15711744)
1. Gender differences in the administration of prophylaxis to prevent deep venous thrombosis.
Kucher N; Tapson VF; Quiroz R; Mir SS; Morrison RB; McKenzie D; Goldhaber SZ;
Thromb Haemost; 2005 Feb; 93(2):284-8. PubMed ID: 15711744
[TBL] [Abstract][Full Text] [Related]
2. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Amin AN; Lin J; Thompson S; Wiederkehr D
Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
[TBL] [Abstract][Full Text] [Related]
3. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk.
Sandoval JA; Sheehan MP; Stonerock CE; Shafique S; Rescorla FJ; Dalsing MC
J Vasc Surg; 2008 Apr; 47(4):837-43. PubMed ID: 18295440
[TBL] [Abstract][Full Text] [Related]
4. Use of deep vein thrombosis prophylaxis in hospitalized cancer patients.
Awar Z; Sheikh-Taha M
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):571-4. PubMed ID: 19587584
[TBL] [Abstract][Full Text] [Related]
5. Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: a survey of healthcare professionals.
Lloyd NS; Douketis JD; Cheng J; Schünemann HJ; Cook DJ; Thabane L; Pai M; Spencer FA; Haynes RB
J Hosp Med; 2012 Jan; 7(1):28-34. PubMed ID: 22038793
[TBL] [Abstract][Full Text] [Related]
6. Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes.
O'Connor C; Adhikari NK; DeCaire K; Friedrich JO
J Hosp Med; 2009 Feb; 4(2):81-9. PubMed ID: 19219912
[TBL] [Abstract][Full Text] [Related]
7. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
8. Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients.
Louis SG; Sato M; Geraci T; Anderson R; Cho SD; Van PY; Barton JS; Riha GM; Underwood S; Differding J; Watters JM; Schreiber MA
JAMA Surg; 2014 Apr; 149(4):365-70. PubMed ID: 24577627
[TBL] [Abstract][Full Text] [Related]
9. Should orthopedic outpatients with lower limb casts be given deep vein thrombosis prophylaxis?
Thomas S; Van Kampen M
Clin Appl Thromb Hemost; 2011 Aug; 17(4):405-7. PubMed ID: 20547549
[TBL] [Abstract][Full Text] [Related]
10. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence.
Bosson JL; Labarere J; Sevestre MA; Belmin J; Beyssier L; Elias A; Franco A; Le Roux P
Arch Intern Med; 2003 Nov; 163(21):2613-8. PubMed ID: 14638561
[TBL] [Abstract][Full Text] [Related]
11. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients.
Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM
J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562
[TBL] [Abstract][Full Text] [Related]
12. [Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients].
Sun KK; Wang C; Pang BS; Yang YH; He W; Chen TF; Zhao QH; Zhang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1019-23. PubMed ID: 15769354
[TBL] [Abstract][Full Text] [Related]
13. Incidence of deep vein thrombosis after spinal cord injury: a prospective study in 37 consecutive patients with traumatic or nontraumatic spinal cord injury treated by mechanical prophylaxis.
Chung SB; Lee SH; Kim ES; Eoh W
J Trauma; 2011 Oct; 71(4):867-70; discussion 870-1. PubMed ID: 21986735
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients.
Kucher N; Tapson VF; Goldhaber SZ;
Thromb Haemost; 2005 Mar; 93(3):494-8. PubMed ID: 15735800
[TBL] [Abstract][Full Text] [Related]
15. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.
Vaitkus PT; Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Goldhaber SZ;
Thromb Haemost; 2005 Jan; 93(1):76-9. PubMed ID: 15630494
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years.
Koopman K; Uyttenboogaart M; Vroomen PC; van der Meer J; De Keyser J; Luijckx GJ
Thromb Haemost; 2009 Oct; 102(4):620-2. PubMed ID: 19806246
[TBL] [Abstract][Full Text] [Related]
17. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
[TBL] [Abstract][Full Text] [Related]
18. Observational cohort study of pediatric inpatients with central venous catheters at "intermediate risk" of thrombosis and eligible for anticoagulant prophylaxis.
Harney KM; McCabe M; Branowicki P; Kalish LA; Neufeld EJ
J Pediatr Oncol Nurs; 2010; 27(6):325-9. PubMed ID: 20657002
[TBL] [Abstract][Full Text] [Related]
19. Deep venous thrombosis prophylaxis in cerebral hemorrhage.
Zubkov AY; Wijdicks EF
Rev Neurol Dis; 2009; 6(1):21-5. PubMed ID: 19367220
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of prophylaxis for deep vein thrombosis in acute hospital trusts.
Campbell SE; Walke AE; Grimshaw JM; Campbell MK; Lowe GD; Harper D; Fowkes FG; Petrie JC;
Int J Qual Health Care; 2001 Aug; 13(4):309-16. PubMed ID: 11560350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
